Jeremy Bender
CIK 1863107 · CHIEF EXECUTIVE OFFICER · last filed 2026-04-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.8K
Companies
3
Total Filings
45
Lifetime Open-Market Net
-$5.43M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | CHIEF EXECUTIVE OFFICER | 0 | $21.53 | $0 | -$5.43M | 39 | 2026-04-23 |
| MREO | Director | 12,550 | $0.30 | $3.8K | $0 | 4 | 2026-02-27 |
| Fusion Pharmaceuticals Inc. (FUSN) Delisted | Director | — | $21.55 | — | $0 | 2 | 2024-06-04 |
Recent Filings · Page 4 of 5
45 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-24 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −12,500 | -$275.0K | EDGAR |
| 2023-01-19 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-22 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −12,500 | -$254.0K | EDGAR |
| 2022-11-22 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −12,500 | -$259.5K | EDGAR |
| 2022-11-17 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +2,049 | -$32.5K | EDGAR |
| 2022-11-03 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −12,500 | -$250.4K | EDGAR |
| 2022-10-05 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −12,500 | -$250.6K | EDGAR |
| 2022-09-06 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −12,500 | -$290.6K | EDGAR |
| 2022-09-06 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Sell (S) | −12,500 | -$290.6K | EDGAR |
| 2022-08-17 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | +6,683 | -$97.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.